Eva Wesley, Author at Born2Invest

Eva Wesley

Eva Wesley is an experienced journalist, market trader, and financial executive. Driven by excellence and a passion to connect with people, she takes pride in writing think pieces that help people decide what to do with their investments. A blockchain enthusiast, she also engages in cryptocurrency trading. Her latest travels have also opened her eyes to other exciting markets, such as aerospace, cannabis, healthcare, and telcos.

Born2Invest uses cookies in order to improve your experience and make further customizations to how we present our content. By continuing to use our website, you accept and give your consent to our practices as described in the following: our revised Privacy Policy, Cookie Policy, and Terms of Use.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Born2Invest

Eva Wesley

Stories By Eva Wesley

Better Care Enters the US with a View to Billing 5 Million in 2024

The ‘Bialert Sepsis’ AI Can Predict a Septic Crisis 24 Hours in Advance in 96% of Cases

Oryzon Requests the Start of Trading of 378,918 New Shares after Increasing its Capital

SJD and the Amancio Ortega Foundation Will Create a Research Center for Rare Diseases

Digital Health: An Opportunity to Attract 70% for Hospitals and 30% for Mutual Insurance Companies

Investment in R&D by Biotech Companies Grows by 17%, up to 1.21 Billion Euros

Neuraxpharm Anticipates 13% Growth in 2024 and a Boost to Production in Spain

GSK Drives Advances in AI and Emerging Technologies to Improve Healthcare

LEO Pharma Grows 6.9% in 2023 and Has a Turnover of 93.2 Million Euros

Grifols Completes the 300 Million Increase in its Private Senior Bond Issue